o NoneEntity Type
0001293310
KALOBIOS PHARMACEUTICALS INC
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 HUMANIGEN, INC
Jurisdiction of Incorporation/OrganizationDELAWARE 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 HUMANIGEN, INC 
Street Address 1Street Address 2
 533 AIRPORT BLVD. SUITE 400
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 BURLINGAME CALIFORNIA 94010 650-243-3100 



3. Related Persons
Last NameFirst NameMiddle Name
DurrantCameron
Street Address 1Street Address 2
533 Airport BoulevardSuite 400
CityState/Province/CountryZIP/Postal Code
BurlingameCALIFORNIA94010
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 Chief Executive Officer, Interim Chief Financial Officer, and Chairman of the Board

Last NameFirst NameMiddle Name
BarliantRonald
Street Address 1Street Address 2
533 Airport BoulevardSuite 400
CityState/Province/CountryZIP/Postal Code
BurlingameCALIFORNIA94010
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
MorrisTimothy
Street Address 1Street Address 2
533 Airport BoulevardSuite 400
CityState/Province/CountryZIP/Postal Code
BurlingameCALIFORNIA94010
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
SavageRobert
Street Address 1Street Address 2
533 Airport BoulevardSuite 400
CityState/Province/CountryZIP/Postal Code
BurlingameCALIFORNIA94010
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 
Last NameFirst NameMiddle Name
BoehmRainer
Street Address 1Street Address 2
533 Airport BoulevardSuite 400
CityState/Province/CountryZIP/Postal Code
BurlingameCALIFORNIA94010
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  x Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2019-11-08 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? x Yes o No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities o Option, Warrant or Other Right to Acquire Another Security
o Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
  
(Associated) Broker or Dealer o None(Associated) Broker or Dealer CRD Number o None
  
Street Address 1Street Address 2
  
City State/Province/CountryZIP/Postal Code
   
State(s) of Solicitation o All States
 
 



13. Offering and Sales Amounts
Total Offering Amount $ 20494614 USD o Indefinite
Total Amount Sold $ 494614 USD 
Total Remaining to be Sold $ 20000000 USD o Indefinite
 
Clarification of Response (if Necessary)
 Amounts include common stock issued or issuable to Lincoln Park Capital Fund, LLC ("Lincoln Park") pursuant to the purchase agreement dated November 8, 2019 by and between Humanigen, Inc. and Lincoln Park.


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 1


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 0 USD o Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD x
Humanigen (CE) (USOTC:HGEN)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024 Haga Click aquí para más Gráficas Humanigen (CE).
Humanigen (CE) (USOTC:HGEN)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024 Haga Click aquí para más Gráficas Humanigen (CE).

Noticias sobre Humanigen, Inc HGEN

Real-Time news about Humanigen Inc (CE) (OTCMarkets): 0 recent articles

Más de Humanigen, Inc Artículos de Noticias